CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-08 | Greenstreet Yvonne Director | Grant or award | +1,160 | 13,247 | ||
| 2022-06-08 | Greenstreet Yvonne Director | Grant or award · Stock Option (Right to Buy) | +8,225 | 8,225 | ||
| 2022-06-08 | GAUGLER DARYL Chief Operating Officer | Grant or award | +7,900 | 19,394 | ||
| 2022-06-08 | GAUGLER DARYL Chief Operating Officer | Grant or award | +5,000 | 24,394 | ||
| 2022-06-08 | GAUGLER DARYL Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +19,800 | 19,800 | ||
| 2022-06-08 | GAUGLER DARYL Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-06-08 | Froimson Mark Director | Grant or award | +1,160 | 6,068 | ||
| 2022-06-08 | Froimson Mark Director | Grant or award · Stock Option (Right to Buy) | +8,225 | 8,225 | ||
| 2022-06-08 | CHRISTIE CHRISTOPHER Director | Grant or award | +1,160 | 3,486 | ||
| 2022-06-08 | CHRISTIE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +8,225 | 8,225 | ||
| 2022-06-08 | Brege Laura Director | Grant or award | +1,160 | 10,147 | ||
| 2022-06-08 | Brege Laura Director | Grant or award · Stock Option (Right to Buy) | +8,225 | 8,225 | ||
| 2022-06-07 | Williams Kristen Marie Chief Administrative Officer | Sale | −4,649 | $59.51 | $277K | 13,650 |
| 2022-06-07 | REINHARDT MAX President, Rest of World | Sale | −2,433 | $62.00 | $151K | 24,400 |
| 2022-06-07 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Sale | −740 | $59.38 | $44K | 13,830 |
| 2022-06-07 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Sale | −1,830 | $60.40 | $111K | 12,000 |
| 2022-06-06 | STACK DAVID M CEO and Chairman | Sale | −11,965 | $61.37 | $734K | 156,079 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Sale | −2,099 | $61.37 | $129K | 44,357 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Option exercise | +6,250 | $34.38 | $215K | 50,607 |
| 2022-06-06 | WINSTON ROY Chief Medical Officer | Sale | −2,535 | $60.55 | $153K | 48,072 |
Page 15 of 23 · 450 trades